Suppr超能文献

氟喹诺酮类药物的使用与自发性颈内动脉夹层的风险。

Use of fluoroquinolones and the risk of spontaneous cervical artery dissection.

机构信息

U.O. Neurologia, Istituto Ospedaliero Poliambulanza, Brescia, Italy.

Dipartimento di Scienze Cliniche e Sperimentali, Clinica Neurologica, Università degli Studi di Brescia, Brescia, Italy.

出版信息

Eur J Neurol. 2019 Jul;26(7):1028-1031. doi: 10.1111/ene.13917. Epub 2019 Mar 5.

Abstract

BACKGROUND AND PURPOSE

Because of their potential to alter the integrity of collagen and other components of the extracellular matrix, fluoroquinolone antibiotics might be involved in the pathogenesis of spontaneous cervical artery dissection (sCeAD).

METHODS

In the setting of a single-centre case-control study, whether fluoroquinolone use in the 30-day period before the index event is associated with sCeAD (cases) in comparison with a group of age- and sex-matched patients who suffered a first-ever acute cerebral infarction from a cause other than CeAD (non-CeAD IS, controls) was assessed.

RESULTS

Overall, 284 cases (mean age 43.2 ± 10.4 years; 58.5% men) and 568 controls qualified for the analysis. Thirty (10.6%) patients in the sCeAD group and 16 (2.8%) in the non-CeAD IS group were fluoroquinolone users (P ≤ 0.001). The use of these antibiotics was associated with a more than two-fold increased risk of sCeAD [odds ratio (OR) 2.31; 95% confidence interval (CI) 1.00-5.30] after adjusting for confounders. The risk was more substantial in the subgroup of patients with dissection involving the carotid artery (OR 2.78; 95% CI 1.14-6.78), in females (OR 4.58; 95% CI 1.04-20.1) and compared to that conferred by other antibiotics (OR 2.42; 95% CI 1.02-5.75).

CONCLUSIONS

Fluoroquinolones may represent a novel contributing factor involved in the pathogenesis of sCeAD.

摘要

背景与目的

由于氟喹诺酮类抗生素可能改变胶原和细胞外基质的其他成分的完整性,因此它们可能与自发性颈内动脉夹层(sCeAD)的发病机制有关。

方法

在一项单中心病例对照研究中,评估了氟喹诺酮类药物在指数事件前 30 天内的使用情况与 sCeAD(病例)的关系,病例组为首次因非颈内动脉夹层(CeAD)原因导致的急性脑梗死患者,对照组为年龄和性别匹配的首次因非 CeAD 原因导致的急性脑梗死患者。

结果

共有 284 例患者(平均年龄 43.2±10.4 岁;58.5%为男性)和 568 例对照组患者符合分析标准。sCeAD 组中有 30 例(10.6%)患者和非 CeAD IS 组中有 16 例(2.8%)患者使用氟喹诺酮类药物(P≤0.001)。校正混杂因素后,这些抗生素的使用与 sCeAD 的风险增加两倍以上相关(比值比 2.31;95%置信区间 1.00-5.30)。在涉及颈内动脉夹层的患者亚组中,风险更大(比值比 2.78;95%置信区间 1.14-6.78),在女性中(比值比 4.58;95%置信区间 1.04-20.1)和与其他抗生素相比(比值比 2.42;95%置信区间 1.02-5.75)。

结论

氟喹诺酮类药物可能是 sCeAD 发病机制中的一个新的致病因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验